| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.783 | 0.004 | 0.819 | Antiadrenergic | 0.819 0.004 DBMET02486 0.136 0.04 DBMET02487 | DBMET02486 | |
| 0.782 | 0.004 | 0.818 | Adrenaline antagonist | 0.818 0.004 DBMET02486 0.133 0.04 DBMET02487 | DBMET02486 | |
| 0.755 | 0.005 | 0.76 | Spasmolytic | 0.76 0.005 DBMET02486 0.681 0.007 DBMET02487 | DBMET02486 | |
| 0.696 | 0.005 | 0.696 | Cardiotonic | 0.672 0.005 DBMET02486 0.391 0.03 DBMET02487 | ||
| 0.691 | 0.005 | 0.811 | Vasodilator, coronary | 0.661 0.005 DBMET02486 0.811 0.004 DBMET02487 | DBMET02487 | |
| 0.661 | 0.009 | 0.661 | 5 Hydroxytryptamine release stimulant | 0.412 0.043 DBMET02486 0.429 0.04 DBMET02487 | ||
| 0.605 | 0.002 | 0.605 | Beta adrenoreceptor antagonist | 0.497 0.002 DBMET02486 0.093 0.02 DBMET02487 | ||
| 0.607 | 0.015 | 0.689 | Vasodilator, peripheral | 0.689 0.007 DBMET02486 0.452 0.04 DBMET02487 | DBMET02486 | |
| 0.537 | 0.002 | 0.537 | Beta 1 adrenoreceptor antagonist | 0.422 0.002 DBMET02486 0.065 0.031 DBMET02487 | ||
| 0.506 | 0.004 | 0.593 | Anesthetic local | 0.593 0.004 DBMET02486 | DBMET02486 | |
| 0.484 | 0.002 | 0.541 | Adrenaline agonist | 0.541 0.002 DBMET02486 0.091 0.044 DBMET02487 | DBMET02486 | |
| 0.48 | 0.002 | 0.48 | Beta 2 adrenoreceptor antagonist | 0.422 0.002 DBMET02486 0.062 0.022 DBMET02487 | ||
| 0.461 | 0.002 | 0.461 | Beta 3 adrenoreceptor antagonist | 0.402 0.002 DBMET02486 0.069 0.036 DBMET02487 | ||
| 0.458 | 0.015 | 0.46 | Vasodilator | 0.455 0.016 DBMET02486 0.46 0.015 DBMET02487 | DBMET02487 | |
| 0.446 | 0.004 | 0.446 | Nav1.3 sodium channel blocker | 0.296 0.009 DBMET02486 | ||
| 0.481 | 0.039 | 0.481 | 5 Hydroxytryptamine release inhibitor | 0.464 0.046 DBMET02486 0.416 0.069 DBMET02487 | ||
| 0.474 | 0.033 | 0.79 | Antithrombotic | 0.413 0.046 DBMET02486 0.79 0.004 DBMET02487 | DBMET02487 | |
| 0.417 | 0.013 | 0.417 | Sodium/bile acid cotransporter inhibitor | 0.415 0.013 DBMET02486 0.353 0.038 DBMET02487 | ||
| 0.405 | 0.006 | 0.405 | Insulin sensitizer | 0.396 0.007 DBMET02486 0.247 0.036 DBMET02487 | ||
| 0.415 | 0.02 | 0.421 | Psychostimulant | 0.421 0.019 DBMET02486 0.298 0.043 DBMET02487 | DBMET02486 | |
| 0.388 | 0.002 | 0.447 | Beta adrenoreceptor agonist | 0.447 0.002 DBMET02486 0.054 0.012 DBMET02487 | DBMET02486 | |
| 0.426 | 0.077 | 0.633 | Cyclophilin D inhibitor | 0.42 0.08 DBMET02486 0.633 0.022 DBMET02487 | DBMET02487 | |
| 0.351 | 0.021 | 0.351 | P-glycoprotein inhibitor | 0.295 0.03 DBMET02486 0.199 0.064 DBMET02487 | ||
| 0.345 | 0.017 | 0.345 | Diuretic | 0.145 0.082 DBMET02486 0.33 0.018 DBMET02487 | ||
| 0.393 | 0.068 | 0.479 | Antiobesity | 0.479 0.042 DBMET02486 0.279 0.132 DBMET02487 | DBMET02486 | |
| 0.348 | 0.038 | 0.564 | Hypoglycemic | 0.291 0.056 DBMET02486 0.564 0.01 DBMET02487 | DBMET02487 | |
| 0.339 | 0.037 | 0.339 | Transcription factor STAT3 inhibitor | 0.211 0.12 DBMET02486 | ||
| 0.379 | 0.086 | 0.445 | Histamine release inhibitor | 0.382 0.085 DBMET02486 0.445 0.052 DBMET02487 | DBMET02487 | |
| 0.352 | 0.064 | 0.596 | Immunostimulant | 0.338 0.068 DBMET02486 0.596 0.017 DBMET02487 | DBMET02487 | |
| 0.318 | 0.037 | 0.318 | 5 Hydroxytryptamine uptake stimulant | 0.22 0.118 DBMET02486 | ||
| 0.304 | 0.027 | 0.345 | DNA methylase inhibitor | 0.176 0.096 DBMET02486 0.345 0.018 DBMET02487 | DBMET02487 | |
| 0.28 | 0.017 | 0.28 | Phospholipase A2 inhibitor | 0.16 0.065 DBMET02486 0.278 0.017 DBMET02487 | ||
| 0.329 | 0.074 | 0.568 | Cholesterol antagonist | 0.337 0.07 DBMET02486 0.568 0.023 DBMET02487 | DBMET02487 | |
| 0.307 | 0.052 | 0.307 | Transcription factor STAT inhibitor | 0.199 0.14 DBMET02486 | ||
| 0.271 | 0.02 | 0.342 | Alpha-N-acetylglucosaminidase inhibitor | 0.252 0.023 DBMET02486 0.342 0.012 DBMET02487 | DBMET02487 | |
| 0.269 | 0.019 | 0.269 | Nav1.2 sodium channel blocker | 0.18 0.042 DBMET02486 | ||
| 0.331 | 0.083 | 0.664 | Transcription factor NF kappa B inhibitor | 0.278 0.108 DBMET02486 0.664 0.025 DBMET02487 | DBMET02487 | |
| 0.278 | 0.035 | 0.278 | DNA methyltransferase I inhibitor | 0.161 0.094 DBMET02486 0.26 0.043 DBMET02487 | ||
| 0.273 | 0.036 | 0.273 | Neuropeptide Y2 antagonist | 0.221 0.087 DBMET02486 | ||
| 0.254 | 0.019 | 0.254 | Insulin secretagoues | 0.211 0.031 DBMET02486 0.24 0.021 DBMET02487 | ||
| 0.238 | 0.005 | 0.259 | Adenylate cyclase stimulant | 0.259 0.004 DBMET02486 0.168 0.037 DBMET02487 | DBMET02486 | |
| 0.28 | 0.046 | 0.28 | Anticonvulsant | |||
| 0.28 | 0.048 | 0.28 | Gastrin inhibitor | 0.236 0.097 DBMET02486 0.208 0.138 DBMET02487 | ||
| 0.361 | 0.137 | 0.361 | Caspase 9 stimulant | 0.288 0.207 DBMET02486 0.342 0.152 DBMET02487 | ||
| 0.281 | 0.058 | 0.416 | Interleukin agonist | 0.324 0.037 DBMET02486 0.416 0.016 DBMET02487 | DBMET02487 | |
| 0.254 | 0.042 | 0.254 | Growth hormone agonist | 0.178 0.068 DBMET02486 0.133 0.103 DBMET02487 | ||
| 0.266 | 0.056 | 0.266 | Interleukin antagonist | 0.256 0.059 DBMET02486 | ||
| 0.207 | 0.002 | 0.207 | Beta 2 adrenoreceptor agonist | 0.2 0.002 DBMET02486 0.067 0.026 DBMET02487 | ||
| 0.261 | 0.058 | 0.261 | Tyrosine 3 hydroxylase inhibitor | 0.193 0.149 DBMET02486 | ||
| 0.275 | 0.073 | 0.275 | Aldehyde oxidase inhibitor | 0.206 0.101 DBMET02486 | ||
| 0.218 | 0.017 | 0.218 | Toll-Like receptor 2 antagonist | 0.145 0.056 DBMET02486 0.116 0.082 DBMET02487 | ||
| 0.266 | 0.065 | 0.266 | Superoxide dismutase inhibitor | 0.206 0.111 DBMET02486 | ||
| 0.21 | 0.011 | 0.21 | Alcohol dehydrogenase inhibitor | 0.129 0.029 DBMET02487 | ||
| 0.249 | 0.051 | 0.356 | Peptidyltransferase inhibitor | 0.319 0.019 DBMET02486 0.356 0.011 DBMET02487 | DBMET02487 | |
| 0.275 | 0.094 | 0.443 | Interleukin 2 agonist | 0.288 0.083 DBMET02486 0.443 0.017 DBMET02487 | DBMET02487 | |
| 0.195 | 0.016 | 0.195 | Catalase inhibitor | 0.185 0.018 DBMET02486 | ||
| 0.213 | 0.034 | 0.213 | Interleukin 6 antagonist | 0.202 0.039 DBMET02486 0.158 0.078 DBMET02487 | ||
| 0.177 | 0.002 | 0.266 | Beta 1 adrenoreceptor agonist | 0.266 0.002 DBMET02486 | DBMET02486 | |
| 0.261 | 0.087 | 0.261 | Insulysin inhibitor | |||
| 0.226 | 0.053 | 0.244 | Nitric-oxide synthase stimulant | 0.244 0.037 DBMET02486 0.186 0.115 DBMET02487 | DBMET02486 | |
| 0.317 | 0.143 | 0.475 | Calcium channel L-type activator | 0.475 0.038 DBMET02486 | DBMET02486 | |
| 0.172 | 0.009 | 0.172 | Aminopeptidase I inhibitor | 0.122 0.019 DBMET02486 | ||
| 0.188 | 0.028 | 0.188 | Adenylate cyclase inhibitor | 0.159 0.039 DBMET02486 0.13 0.06 DBMET02487 | ||
| 0.178 | 0.024 | 0.178 | Nav1.1 sodium channel blocker | 0.153 0.032 DBMET02486 | ||
| 0.155 | 0.002 | 0.247 | Beta 3 adrenoreceptor agonist | 0.247 0.002 DBMET02486 | DBMET02486 | |
| 0.178 | 0.027 | 0.178 | Aminopeptidase B inhibitor | 0.119 0.053 DBMET02486 | ||
| 0.174 | 0.025 | 0.174 | Nav1.4 sodium channel blocker | 0.132 0.043 DBMET02486 0.108 0.065 DBMET02487 | ||
| 0.159 | 0.012 | 0.159 | Somatostatin 1 agonist | 0.158 0.012 DBMET02486 0.111 0.028 DBMET02487 | ||
| 0.163 | 0.02 | 0.186 | Sphingomyelinase inhibitor | 0.186 0.013 DBMET02486 0.14 0.029 DBMET02487 | DBMET02486 | |
| 0.229 | 0.086 | 0.229 | Calpain inhibitor | 0.184 0.129 DBMET02486 | ||
| 0.189 | 0.047 | 0.283 | ATPase inhibitor | 0.283 0.008 DBMET02487 | DBMET02487 | |
| 0.219 | 0.08 | 0.278 | Cyclic AMP phosphodiesterase inhibitor | 0.278 0.051 DBMET02486 0.185 0.106 DBMET02487 | DBMET02486 | |
| 0.159 | 0.024 | 0.169 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.104 0.05 DBMET02486 0.169 0.022 DBMET02487 | DBMET02487 | |
| 0.267 | 0.136 | 0.45 | Immunosuppressant | 0.234 0.162 DBMET02486 0.45 0.047 DBMET02487 | DBMET02487 | |
| 0.152 | 0.022 | 0.156 | Calcium antagonist | 0.156 0.021 DBMET02486 | DBMET02486 | |
| 0.172 | 0.043 | 0.172 | Calcium channel blocker | |||
| 0.153 | 0.03 | 0.236 | Bronchodilator | 0.236 0.014 DBMET02486 | DBMET02486 | |
| 0.126 | 0.005 | 0.126 | Sphingosine 1-phosphate receptor 3 agonist | 0.122 0.005 DBMET02486 | ||
| 0.162 | 0.041 | 0.162 | Nav1.6 sodium channel blocker | 0.13 0.081 DBMET02486 | ||
| 0.152 | 0.031 | 0.172 | Mucolytic | 0.172 0.022 DBMET02486 0.132 0.044 DBMET02487 | DBMET02486 | |
| 0.144 | 0.026 | 0.144 | NMDA receptor antagonist | 0.116 0.037 DBMET02486 | ||
| 0.139 | 0.024 | 0.139 | Factor V inhibitor | 0.132 0.029 DBMET02486 0.111 0.05 DBMET02487 | ||
| 0.156 | 0.042 | 0.156 | Cathepsin H inhibitor | 0.104 0.1 DBMET02486 | ||
| 0.129 | 0.016 | 0.129 | Histamine H2 receptor antagonist | 0.097 0.037 DBMET02486 | ||
| 0.113 | 0.005 | 0.113 | Epithelial sodium channel blocker | 0.077 0.014 DBMET02486 0.051 0.047 DBMET02487 | ||
| 0.141 | 0.034 | 0.141 | Protease inhibitor | 0.123 0.045 DBMET02486 0.1 0.066 DBMET02487 | ||
| 0.167 | 0.06 | 0.196 | Acetylcholine M1 receptor antagonist | 0.196 0.044 DBMET02486 | DBMET02486 | |
| 0.111 | 0.004 | 0.111 | Plasmepsin II inhibitor | 0.061 0.011 DBMET02486 | ||
| 0.152 | 0.046 | 0.152 | Proteasome inhibitor | |||
| 0.158 | 0.053 | 0.158 | Neuropeptide Y1 antagonist | 0.123 0.116 DBMET02486 | ||
| 0.117 | 0.013 | 0.117 | Cathepsin D inhibitor | 0.094 0.02 DBMET02486 | ||
| 0.121 | 0.018 | 0.163 | Phenylalanine 4-hydroxylase inhibitor | 0.163 0.01 DBMET02486 | DBMET02486 | |
| 0.145 | 0.044 | 0.145 | Vanilloid 1 agonist | 0.134 0.06 DBMET02487 | ||
| 0.169 | 0.074 | 0.169 | Phospholipase C inhibitor | 0.138 0.133 DBMET02486 0.141 0.126 DBMET02487 | ||
| 0.165 | 0.071 | 0.278 | Thrombolytic | 0.121 0.11 DBMET02486 0.278 0.028 DBMET02487 | DBMET02487 | |
| 0.098 | 0.004 | 0.112 | Sphingosine 1-phosphate receptor 1 agonist | 0.112 0.004 DBMET02486 | DBMET02486 | |
| 0.094 | 0.004 | 0.104 | Calcium-sensing receptor antagonist | 0.104 0.004 DBMET02486 | DBMET02486 | |
| 0.205 | 0.116 | 0.364 | DNA synthesis inhibitor | 0.189 0.141 DBMET02486 0.364 0.028 DBMET02487 | DBMET02487 | |
| 0.104 | 0.016 | 0.113 | Secretase beta inhibitor | 0.113 0.012 DBMET02486 | DBMET02486 | |
| 0.092 | 0.006 | 0.099 | Sphingosine 1-phosphate receptor agonist | 0.099 0.005 DBMET02486 | DBMET02486 | |
| 0.112 | 0.028 | 0.122 | Glutamate release inhibitor | 0.121 0.021 DBMET02486 0.122 0.021 DBMET02487 | DBMET02487 | |
| 0.147 | 0.065 | 0.147 | Histone deacetylase SIRT1 inhibitor | |||
| 0.15 | 0.069 | 0.15 | Thiol protease inhibitor | 0.121 0.115 DBMET02486 | ||
| 0.224 | 0.144 | 0.224 | Ca(v)3.3 blocker | |||
| 0.182 | 0.104 | 0.539 | Angiogenesis stimulant | 0.135 0.132 DBMET02486 0.539 0.01 DBMET02487 | DBMET02487 | |
| 0.111 | 0.033 | 0.111 | Ornithine decarboxylase inhibitor | 0.111 0.033 DBMET02486 | ||
| 0.089 | 0.011 | 0.089 | Sphingosine kinase inhibitor | 0.057 0.044 DBMET02486 | ||
| 0.116 | 0.039 | 0.116 | MAP kinase kinase 1 inhibitor | 0.098 0.059 DBMET02486 | ||
| 0.1 | 0.025 | 0.1 | Estrogen-related receptor beta agonist | |||
| 0.123 | 0.049 | 0.242 | Expectorant | 0.152 0.034 DBMET02486 0.242 0.014 DBMET02487 | DBMET02487 | |
| 0.234 | 0.161 | 0.234 | Calpain 2 inhibitor | 0.224 0.168 DBMET02486 | ||
| 0.135 | 0.062 | 0.235 | Cyclooxygenase 3 inhibitor | 0.109 0.091 DBMET02486 0.235 0.01 DBMET02487 | DBMET02487 | |
| 0.179 | 0.107 | 0.179 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.121 | 0.053 | 0.121 | Nav1.5 sodium channel blocker | |||
| 0.099 | 0.031 | 0.099 | Glutamate dehydrogenase inhibitor | 0.084 0.041 DBMET02486 | ||
| 0.08 | 0.012 | 0.08 | 5 Hydroxytryptamine 1B agonist | 0.065 0.022 DBMET02486 | ||
| 0.16 | 0.095 | 0.16 | Succinate dehydrogenase inhibitor | 0.147 0.118 DBMET02486 | ||
| 0.079 | 0.016 | 0.079 | Sphingosine kinase 2 inhibitor | 0.05 0.047 DBMET02486 | ||
| 0.094 | 0.033 | 0.115 | Glutamate decarboxylase inhibitor | 0.115 0.022 DBMET02486 | DBMET02486 | |
| 0.104 | 0.044 | 0.146 | Triose-phosphate isomerase inhibitor | 0.105 0.043 DBMET02486 0.146 0.021 DBMET02487 | DBMET02487 | |
| 0.07 | 0.011 | 0.07 | Immunoglobulin Fc receptor antagonist | 0.052 0.049 DBMET02486 | ||
| 0.137 | 0.078 | 0.259 | Cell wall synthesis inhibitor | 0.187 0.036 DBMET02486 0.259 0.014 DBMET02487 | DBMET02487 | |
| 0.076 | 0.018 | 0.076 | Bombesin 2 receptor antagonist | |||
| 0.072 | 0.015 | 0.094 | Alpha-mannosidase inhibitor | 0.074 0.014 DBMET02486 0.094 0.007 DBMET02487 | DBMET02487 | |
| 0.091 | 0.037 | 0.091 | Keratolytic | 0.078 0.052 DBMET02486 | ||
| 0.109 | 0.056 | 0.174 | Toll-Like receptor 4 antagonist | 0.102 0.067 DBMET02486 0.174 0.011 DBMET02487 | DBMET02487 | |
| 0.058 | 0.005 | 0.058 | Plasmepsin I inhibitor | 0.052 0.007 DBMET02486 0.028 0.023 DBMET02487 | ||
| 0.138 | 0.084 | 0.443 | Hemostatic | 0.443 0.005 DBMET02487 | DBMET02487 | |
| 0.065 | 0.014 | 0.099 | Mannosidase inhibitor | 0.069 0.012 DBMET02486 0.099 0.006 DBMET02487 | DBMET02487 | |
| 0.078 | 0.029 | 0.078 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.212 | 0.164 | 0.439 | Apoptosis antagonist | 0.246 0.132 DBMET02486 0.439 0.029 DBMET02487 | DBMET02487 | |
| 0.058 | 0.01 | 0.058 | Sphingosine kinase 1 inhibitor | |||
| 0.171 | 0.124 | 0.278 | Platelet antagonist | 0.278 0.061 DBMET02487 | DBMET02487 | |
| 0.083 | 0.036 | 0.083 | Calcium channel L-type blocker | |||
| 0.103 | 0.057 | 0.103 | Creatine kinase inhibitor | 0.086 0.077 DBMET02486 | ||
| 0.071 | 0.025 | 0.071 | Ornithine carbamoyltransferase inhibitor | 0.059 0.032 DBMET02486 | ||
| 0.149 | 0.104 | 0.149 | Neurotensin receptor agonist | |||
| 0.071 | 0.026 | 0.071 | Acyl-CoA dehydrogenase inhibitor | 0.061 0.032 DBMET02486 | ||
| 0.115 | 0.072 | 0.123 | Acetylcholine muscarinic antagonist | 0.123 0.064 DBMET02486 | DBMET02486 | |
| 0.08 | 0.037 | 0.325 | Selectin antagonist | 0.071 0.042 DBMET02486 0.325 0.005 DBMET02487 | DBMET02487 | |
| 0.091 | 0.048 | 0.091 | Hematopoietic | |||
| 0.07 | 0.029 | 0.073 | Cathepsin E inhibitor | 0.073 0.027 DBMET02486 | DBMET02486 | |
| 0.061 | 0.022 | 0.061 | Lysophosphatidic acid 3 receptor antagonist | 0.058 0.024 DBMET02486 | ||
| 0.056 | 0.017 | 0.063 | Neuraminidase (Influenza A) inhibitor | 0.058 0.015 DBMET02486 0.063 0.01 DBMET02487 | DBMET02487 | |
| 0.054 | 0.016 | 0.054 | HIV-1 protease inhibitor | 0.046 0.026 DBMET02486 | ||
| 0.129 | 0.092 | 0.235 | Peroxidase inhibitor | 0.235 0.051 DBMET02486 | DBMET02486 | |
| 0.15 | 0.114 | 0.171 | Anesthetic general | 0.171 0.094 DBMET02487 | DBMET02487 | |
| 0.066 | 0.03 | 0.072 | Sphingosine 1-phosphate receptor 3 antagonist | 0.072 0.024 DBMET02486 | DBMET02486 | |
| 0.055 | 0.02 | 0.055 | Oxytocin agonist | |||
| 0.119 | 0.086 | 0.147 | Interleukin 4 antagonist | 0.147 0.052 DBMET02487 | DBMET02487 | |
| 0.065 | 0.032 | 0.065 | Alcohol oxidase inhibitor | 0.054 0.041 DBMET02486 | ||
| 0.072 | 0.04 | 0.072 | Glucagon-like peptide 1 agonist | |||
| 0.037 | 0.007 | 0.037 | Vasopressin 1A agonist | 0.027 0.024 DBMET02486 0.027 0.023 DBMET02487 | ||
| 0.068 | 0.039 | 0.117 | Neuraminidase (influenza) inhibitor | 0.087 0.021 DBMET02486 0.117 0.012 DBMET02487 | DBMET02487 | |
| 0.062 | 0.033 | 0.062 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.063 | 0.035 | 0.063 | Ribonucleotide reductase inhibitor | |||
| 0.097 | 0.07 | 0.097 | Folate antagonist | 0.093 0.081 DBMET02487 | ||
| 0.063 | 0.037 | 0.063 | Neuropeptide agonist | 0.047 0.045 DBMET02486 | ||
| 0.033 | 0.008 | 0.033 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 DBMET02486 | ||
| 0.065 | 0.04 | 0.065 | Calcium channel P-type blocker | |||
| 0.073 | 0.048 | 0.073 | Histidine decarboxylase inhibitor | |||
| 0.112 | 0.088 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.063 | 0.04 | 0.097 | Neuraminidase inhibitor | 0.083 0.023 DBMET02486 0.097 0.016 DBMET02487 | DBMET02487 | |
| 0.036 | 0.013 | 0.036 | Vasopressin 1B antagonist | |||
| 0.028 | 0.005 | 0.028 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 DBMET02486 | ||
| 0.095 | 0.074 | 0.095 | Carbonic anhydrase XV inhibitor | |||
| 0.061 | 0.04 | 0.078 | Carbonic anhydrase stimulant | 0.078 0.027 DBMET02486 | DBMET02486 | |
| 0.04 | 0.02 | 0.04 | Calcitonin receptor agonist | 0.029 0.028 DBMET02486 | ||
| 0.057 | 0.037 | 0.057 | Human rhinovirus A protease inhibitor | 0.049 0.045 DBMET02486 | ||
| 0.032 | 0.012 | 0.032 | Antidiuretic hormone agonist | |||
| 0.042 | 0.022 | 0.042 | Vascular adhesion protein 1 inhibitor | |||
| 0.153 | 0.133 | 0.227 | Hypolipemic | 0.169 0.119 DBMET02486 0.227 0.079 DBMET02487 | DBMET02487 | |
| 0.102 | 0.082 | 0.102 | Calcium channel (voltage-sensitive) blocker | |||
| 0.042 | 0.022 | 0.042 | Oxytocin antagonist | |||
| 0.061 | 0.042 | 0.061 | Cannabinoid CB1 receptor agonist | |||
| 0.041 | 0.022 | 0.05 | Diamine oxidase inhibitor | 0.05 0.015 DBMET02486 | DBMET02486 | |
| 0.037 | 0.02 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.027 | 0.012 | 0.027 | Aminopeptidase P inhibitor | 0.023 0.017 DBMET02486 | ||
| 0.025 | 0.01 | 0.025 | Vasopressin 1 agonist | |||
| 0.062 | 0.048 | 0.062 | Neutrophil collagenase inhibitor | |||
| 0.104 | 0.09 | 0.104 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.039 | 0.026 | 0.041 | Somatostatin 1 antagonist | 0.041 0.026 DBMET02486 | DBMET02486 | |
| 0.09 | 0.078 | 0.094 | Anabolic | 0.094 0.072 DBMET02486 | DBMET02486 | |
| 0.055 | 0.042 | 0.055 | Kallikrein 1 inhibitor | |||
| 0.122 | 0.11 | 0.244 | Anticoagulant | 0.124 0.107 DBMET02486 0.244 0.04 DBMET02487 | DBMET02487 | |
| 0.093 | 0.081 | 0.094 | Adenylate kinase inhibitor | 0.094 0.079 DBMET02486 | DBMET02486 | |
| 0.103 | 0.092 | 0.103 | Cholinergic antagonist | |||
| 0.057 | 0.046 | 0.057 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.061 | 0.053 | 0.061 | Matrix metalloproteinase inhibitor | |||
| 0.083 | 0.076 | 0.083 | Prolactin inhibitor | |||
| 0.034 | 0.027 | 0.034 | Growth factor receptor-bound protein 2 antagonist | |||
| 0.058 | 0.051 | 0.058 | NMDA receptor agonist | |||
| 0.038 | 0.031 | 0.038 | Toll-Like receptor 2 agonist | 0.036 0.034 DBMET02486 0.038 0.031 DBMET02487 | ||
| 0.068 | 0.061 | 0.068 | Metalloproteinase-9 inhibitor | 0.066 0.064 DBMET02486 | ||
| 0.058 | 0.052 | 0.068 | Nitric oxide donor | 0.068 0.036 DBMET02487 | DBMET02487 | |
| 0.056 | 0.049 | 0.056 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.03 | 0.024 | 0.044 | Squalene synthetase inhibitor | 0.044 0.017 DBMET02487 | DBMET02487 | |
| 0.017 | 0.011 | 0.017 | Vasopressin 2 agonist | |||
| 0.099 | 0.093 | 0.099 | Acetylcholine antagonist | |||
| 0.115 | 0.109 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.071 | 0.065 | 0.075 | GABA B receptor agonist | 0.075 0.054 DBMET02486 | DBMET02486 | |
| 0.085 | 0.081 | 0.156 | UDP-glucose 4-epimerase inhibitor | 0.156 0.027 DBMET02487 | DBMET02487 | |
| 0.087 | 0.084 | 0.14 | Mediator release inhibitor | 0.14 0.033 DBMET02487 | DBMET02487 | |
| 0.049 | 0.046 | 0.05 | Myc inhibitor | 0.05 0.046 DBMET02486 | DBMET02486 | |
| 0.032 | 0.029 | 0.032 | Renin inhibitor | |||
| 0.049 | 0.047 | 0.049 | Leukotriene B4 antagonist | |||
| 0.1 | 0.098 | 0.1 | Aldehyde dehydrogenase inhibitor | |||
| 0.033 | 0.031 | 0.033 | Melanocortin 1 antagonist | |||
| 0.034 | 0.032 | 0.034 | Cholecystokinin B agonist | |||
| 0.049 | 0.048 | 0.049 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.03 | 0.029 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.079 | 0.079 | 0.091 | Aminoacyl-tRNA synthetase inhibitor | 0.091 0.057 DBMET02486 | DBMET02486 | |
| 0.124 | 0.125 | 0.187 | Interferon gamma antagonist | 0.187 0.046 DBMET02487 | DBMET02487 | |
| 0.077 | 0.078 | 0.132 | Transcription factor NF kappa B stimulant | 0.077 0.076 DBMET02486 0.132 0.02 DBMET02487 | DBMET02487 | |
| 0.077 | 0.081 | 0.142 | NADH dehydrogenase inhibitor | 0.142 0.02 DBMET02487 | DBMET02487 | |
| 0.093 | 0.097 | 0.181 | Alkylator | 0.139 0.053 DBMET02486 0.181 0.032 DBMET02487 | DBMET02487 | |
| 0.029 | 0.043 | 0.063 | Antibiotic Aminoglycoside-like | 0.063 0.008 DBMET02487 | DBMET02487 | |
| 0.091 | 0.106 | 0.304 | Amylase inhibitor | 0.304 0.018 DBMET02487 | DBMET02487 | |
| 0.022 | 0.041 | 0.049 | Arginase inhibitor | 0.049 0.016 DBMET02487 | DBMET02487 | |
| 0.05 | 0.069 | 0.093 | Phosphofructokinase-1 inhibitor | 0.093 0.035 DBMET02487 | DBMET02487 | |
| 0.022 | 0.046 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.014 DBMET02486 0.027 0.022 DBMET02487 | DBMET02486 | |
| 0.013 | 0.043 | 0.025 | Antibiotic Anthracycline-like | 0.025 0.005 DBMET02487 | DBMET02487 | |
| 0.134 | 0.168 | 0.291 | Antiamyloidogenic | 0.194 0.104 DBMET02486 0.291 0.054 DBMET02487 | DBMET02487 | |
| 0.114 | 0.149 | 0.139 | Melanin inhibitor | 0.139 0.099 DBMET02487 | DBMET02487 | |
| 0.085 | 0.123 | 0.113 | Electron transport complex I inhibitor | 0.113 0.057 DBMET02486 | DBMET02486 | |
| 0.139 | 0.179 | 0.436 | Antioxidant | 0.436 0.029 DBMET02487 | DBMET02487 | |
| 0.068 | 0.112 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.086 0.064 DBMET02487 | DBMET02487 | |
| 0.083 | 0.137 | 0.186 | Cell adhesion inhibitor | 0.186 0.029 DBMET02487 | DBMET02487 | |
| 0.013 | 0.068 | 0.035 | Protein 30S ribosomal subunit inhibitor | 0.035 0.011 DBMET02487 | DBMET02487 | |
| 0.084 | 0.141 | 0.188 | Lipid peroxidase inhibitor | 0.188 0.047 DBMET02487 | DBMET02487 | |
| 0.047 | 0.105 | 0.085 | Topoisomerase II alpha inhibitor | 0.085 0.049 DBMET02487 | DBMET02487 | |
| 0.067 | 0.139 | 0.137 | DNA polymerase I inhibitor | 0.137 0.056 DBMET02487 | DBMET02487 | |
| 0.073 | 0.146 | 0.103 | Microtubule formation inhibitor | 0.103 0.086 DBMET02487 | DBMET02487 | |
| 0.175 | 0.262 | 0.578 | Antibacterial | 0.295 0.139 DBMET02486 0.578 0.023 DBMET02487 | DBMET02487 | |
| 0.037 | 0.127 | 0.069 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 DBMET02487 | DBMET02487 | |
| 0.052 | 0.144 | 0.102 | Cell adhesion molecule inhibitor | 0.102 0.033 DBMET02487 | DBMET02487 | |
| 0.071 | 0.171 | 0.111 | Sodium channel blocker | 0.111 0.097 DBMET02486 | DBMET02486 | |
| 0.017 | 0.117 | 0.043 | Phosphorylase inhibitor | 0.043 0.035 DBMET02487 | DBMET02487 | |
| 0.012 | 0.112 | 0.035 | Sodium/glucose cotransporter inhibitor | 0.035 0.009 DBMET02487 | DBMET02487 | |
| 0.009 | 0.11 | 0.036 | Sodium/glucose cotransporter 2 inhibitor | 0.036 0.01 DBMET02487 | DBMET02487 | |
| 0.143 | 0.249 | 0.375 | Immunomodulator | 0.375 0.052 DBMET02487 | DBMET02487 | |
| 0.038 | 0.146 | 0.078 | Adenine nucleotide translocase inhibitor | 0.078 0.01 DBMET02487 | DBMET02487 | |
| 0.062 | 0.178 | 0.11 | Toll-Like receptor 3 antagonist | 0.11 0.038 DBMET02486 | DBMET02486 | |
| 0.059 | 0.179 | 0.176 | AMP-activated protein kinase stimulant | 0.176 0.015 DBMET02487 | DBMET02487 | |
| 0.087 | 0.215 | 0.289 | Nitric oxide antagonist | 0.289 0.043 DBMET02487 | DBMET02487 | |
| 0.037 | 0.173 | 0.162 | Monophenol monooxygenase inhibitor | 0.162 0.043 DBMET02487 | DBMET02487 | |
| 0.083 | 0.221 | 0.297 | Platelet adhesion inhibitor | 0.297 0.035 DBMET02487 | DBMET02487 | |
| 0.022 | 0.162 | 0.131 | Antineoplastic antibiotic | 0.131 0.036 DBMET02487 | DBMET02487 | |
| 0.085 | 0.227 | 0.34 | Hepatoprotectant | 0.34 0.02 DBMET02487 | DBMET02487 | |
| 0.026 | 0.175 | 0.151 | Factor IXa inhibitor | 0.151 0.004 DBMET02486 0.059 0.028 DBMET02487 | DBMET02486 | |
| 0.016 | 0.17 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.011 DBMET02487 | DBMET02487 | |
| 0.038 | 0.195 | 0.056 | Lipocortins synthesis agonist | 0.056 0.047 DBMET02487 | DBMET02487 | |
| 0.089 | 0.251 | 0.386 | Free radical scavenger | 0.386 0.031 DBMET02487 | DBMET02487 | |
| 0.019 | 0.18 | 0.083 | Protein 50S ribosomal subunit inhibitor | 0.083 0.018 DBMET02487 | DBMET02487 | |
| 0.024 | 0.207 | 0.078 | Heparanase inhibitor | 0.078 0.008 DBMET02487 | DBMET02487 | |
| 0.023 | 0.215 | 0.056 | Glucose-6-phosphate translocase inhibitor | 0.056 0.029 DBMET02487 | DBMET02487 | |
| 0.073 | 0.308 | 0.312 | Tumour necrosis factor alpha release inhibitor | 0.312 0.049 DBMET02487 | DBMET02487 | |
| 0.006 | 0.274 | 0.023 | Factor IX inhibitor | 0.023 0.01 DBMET02486 | DBMET02486 | |
| 0.028 | 0.313 | 0.11 | Topoisomerase II inhibitor | 0.11 0.077 DBMET02487 | DBMET02487 | |
| 0.059 | 0.374 | 0.117 | DNA repair enzyme inhibitor | 0.117 0.078 DBMET02487 | DBMET02487 | |
| 0.019 | 0.381 | 0.1 | Topoisomerase I inhibitor | 0.1 0.07 DBMET02487 | DBMET02487 | |
| 0.1 | 0.473 | 0.42 | Apoptosis agonist | 0.42 0.104 DBMET02487 | DBMET02487 | |
| 0.015 | 0.467 | 0.111 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.111 0.076 DBMET02486 | DBMET02486 | |
| 0.014 | 0.467 | 0.111 | Abl kinase inhibitor | 0.111 0.076 DBMET02486 | DBMET02486 | |
| 0.034 | 0.665 | 0.12 | NOS3 expression enhancer | 0.12 0.116 DBMET02487 | DBMET02487 | |
| 0.029 | 0.767 | 0.434 | Antiinflammatory | 0.434 0.119 DBMET02487 | DBMET02487 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |